Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis

NCT02863588 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT02863588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02863588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determination of Genetic Susceptibility in Severe Recurrences of Ocular Toxoplasmosis
Lead sponsor
University Hospital, Strasbourg, France
Phase
Not applicable
Overall status
Terminated
Start date
March 30, 2017
Completion date
November 11, 2019
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genotype ii, ocular toxoplasmosis with recurrences, toxoplasmosis infection